Lunit Inc.
328130
Rang in Aktien
#12063
Lunit Inc., established in 2013 and headquartered in Seoul, South Korea,... Lunit Inc., established in 2013 and headquartered in Seoul, South Korea, develops and supplies advanced artificial intelligence software solutions aimed at improving cancer screening, diagnosis, and treatment. The company's portfolio includes AI-powered tools for analyzing medical images like chest X-rays and mammograms, as well as intelligent biomarkers for immune phenotyping and precise PD-L1 quantification, which are vital for optimizing immunotherapy.
Aktienkurs
$8.60
Marktkapitalisierung
$640.04M
Veränderung (1 Tag)
7.83%
Veränderung (1 Jahr)
1,029.85%
Land
KR
Handel Lunit Inc. (328130)
Kategorie
Healthcare
Kursverlauf für Lunit Inc. (328130)
Höchster Schlusskurs: $0.77 am 2024-05-01
Niedrigster Schlusskurs: $0.36 am 2016-04-01
Niedrigster Schlusskurs: $0.36 am 2016-04-01
Kursverlauf der Aktie von Lunit Inc. von 2016 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2024 | 21.01% |
| 2023 | 63.98% |
| 2022 | -48.35% |
| 2021 | -27.48% |
| 2020 | -16.42% |
| 2019 | 54.09% |
| 2018 | 66.29% |
| 2017 | 3.05% |
| 2016 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $68.99 | -9.39% |
US
|
|
| $133.64 | -27.60% |
AU
|
|
| $62.83 | 90.74% |
US
|
|
| $67.71 | -20.60% |
US
|
|
| $76.26 | 521.98% |
US
|
